Valuation China Resources Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 16:08:25 28/10/2026 HKT			5-day change	1st Jan Change
4.550 ^HKD	-1.30%		-2.26%	+2.25%

10-23	China Resources Pharma Unit Raises 800 Million Yuan Via Bonds Issue	MT
10-19	China Resources Pharma Unit Raises 900 Billion Yuan Via Bonds Issue	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,303	39,705	32,229	35,810	27,957	28,585	-	-
Change	-	78.03%	-18.83%	11.11%	-21.93%	2.25%	-	-
Enterprise Value (EV) ¹	61,337	73,426	71,468	90,725	90,801	77,820	71,114	58,806
Change	-	19.71%	-2.67%	26.95%	0.08%	-14.3%	-8.62%	-17.31%
P/E	5.92x	9.58x	7.76x	10x	6.12x	5.84x	5.47x	5.22x
PBR	0.44x	0.8x	0.32x	0.34x	0.48x	0.44x	0.41x	0.36x
PEG	-	1x	44.15x	-0.7x	0.2x	0.81x	0.82x	1.05x
Capitalization / Revenue	0.09x	0.16x	0.12x	0.13x	0.09x	0.09x	0.08x	0.08x
EV / Revenue	0.26x	0.29x	0.27x	0.33x	0.3x	0.24x	0.21x	0.17x
EV / EBITDA	4.83x	4.38x	4.65x	5.47x	4.73x	3.91x	3.31x	2.83x
EV / EBIT	6.22x	5.39x	5.98x	6.98x	6.23x	4.82x	4.09x	3.35x
EV / FCF	5.88x	7.47x	5.49x	5.73x	4.37x	-28.6x	9.69x	6.52x
FCF Yield	17%	13.4%	18.2%	17.5%	22.9%	-3.49%	10.3%	15.3%
Dividend per Share ²	0.15	0.16	0.1669	0.1445	0.2203	0.2035	0.2202	0.218
Rate of return	4.23%	2.53%	3.25%	2.54%	4.95%	4.47%	4.84%	4.79%
EPS ²	0.6	0.66	0.6612	0.5677	0.7268	0.7794	0.8312	0.8725
Distribution rate	25%	24.2%	25.2%	25.5%	30.3%	26.1%	26.5%	25%
Net sales ¹	236,806	254,106	265,229	275,999	306,131	327,819	340,757	352,428
EBITDA ¹	12,690	16,775	15,382	16,601	19,202	19,905	21,499	20,777
EBIT ¹	9,868	13,623	11,952	13,005	14,567	16,129	17,398	17,536
Net income ¹	3,769	4,147	4,178	3,589	4,594	4,824	5,178	5,377
Net Debt ¹	39,035	33,720	39,238	54,915	62,844	49,235	42,528	30,221
Reference price ²	3.550	6.320	5.130	5.700	4.450	4.550	4.550	4.550
Nbr of stocks (in thousands)	6,282,510	6,282,510	6,282,510	6,282,510	6,282,510	6,282,510	-	-
Announcement Date	29/3/22	30/3/23	26/3/24	26/3/25	24/3/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED	5.92x	0.24x	3.93x	4.42%	3.69B
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,143B
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	647B
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	506B
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	384B
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	350B
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	293B
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	265B
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	242B
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	197B
Average	27.21x	6.40x	17.28x	2.35%	403.12B
Weighted average by Cap.	35.24x	8.35x	20.47x	1.8%